Schepman, Patricia
Pfizer (United States)
2 papers on CoChatORCID 0000-0001-9462-9261
Most cited papers
- Verified
Healthcare resource use and cost associated with timing of pharmacological treatment for major depressive disorder in the United States: a real-world study
McIntyre, R. S., Prieto, R., Schepman, P., Yeh, Y.-C., Boucher, M., Shelbaya, A., Chambers, R., Gao, X., & Pappadopulos, E. (2019) · Current Medical Research and Opinion
Treatment of Major DepressionMental Health Treatment and Access
Cited by 15
- Verified
Risk factors associated with falls and fractures following prescription of opioids among privately insured patients with osteoarthritis
Silverman, S., Schepman, P., Rice, J. B., Beck, C., Pajerowski, W., White, A., Thakkar, S., Robinson, R., & Emir, B. (2022) · Journal of Health Economics and Outcomes Research
Opioid Use Disorder TreatmentPharmaceutical Practices and Patient Outcomes
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free